McKinsey Opened a Door in Its Firewall Between Pharma Clients and Regulators

The firm let consultants advise both drugmakers and their government overseers, internal records show. “Who we know and what we know” was part of their pitch.

The New York Times | Dirección, Legal | Administración Pública, Gestión de Empresas, Salud |

Leer noticia completa en el medio original
Spanish